Welcome to BioMarket Group!

ICT Opportunities in European Financial Services: Investment drivers, targeting strategies and the leading players

Additional Information

Published Date Aug 5, 2005
Special Offer No
Pages 154
PDF Fact Sheet View Fact Sheet for the report ICT Opportunities in European Financial Services: Investment drivers, targeting strategies and the leading players in PDF format.
Published on Date No
Format No
Publisher Business Insights
Product Line No
Full Title ICT Opportunities in European Financial Services: Investment drivers, targeting strategies and the leading players

Availability: In stock

$1,910.00

Quick Overview

The global economic downturn and equity market decline since the late 1990s badly affected the entire financial services industry and resulted in dramatic cuts in IT spending.
Request free sample pages from ICT Opportunities in European Financial Services: Investment drivers, targeting strategies and the leading players

Executive Summary

The global economic downturn and equity market decline since the late 1990s badly affected the entire financial services industry and resulted in dramatic cuts in IT spending. Since then, as markets have stabilized, more balanced strategies focusing on cost containment and efficiency maximization have emerged. However, each financial services sub-sector differs from another and vendors need to understand their dynamics in order to target them successfully. This new technology management report that assesses the key ICT investment drivers in retail banking, insurance and financial markets sectors. The report contains a detailed examination of key market issues including operational risk, compliance, rationalisation and revenue generation. It also evaluates the profiles of leading technology vendors in each market, the market opportunities for vendors and recommends key action points for growth.

Request free sample pages from ICT Opportunities in European Financial Services: Investment drivers, targeting strategies and the leading players

Other selected research from the 'Europe' category:


Benchmarking Best Practice at Patent Expiry in Europe - Maximizing Return on Investment of Late-Stage Lifecycle Management
Successfully managing the lifecycle of molecules within marketed portfolios is an essential capability for the pharma industry. With R&D productivity stalling, and profit margins increasingly eroded by cost containment initiatives, maximizing the return on investment of in-line brands, by extending the time on the market without generic competition, is a key objective for pharmaceutical companies. Learn More


European Vaccine Markets
The European vaccines market has demonstrated growth even through tough economic times. This has mainly been due to the introduction of vaccines in untapped disease markets and government’s acceptance and... Learn More

Other selected research from the 'Finance & Investment' category:


Biotech Exit Strategies: Delivering value to investors in a challenging funding market
Establishing the most effective route to exit for a biotech venture is critical in ensuring value is maximized for key stakeholders and the associated technology. However, more critical than selection of exit strategy is the planning and effective execution of exit. Learn More


ICT Opportunities in European Financial Services: Investment drivers, targeting strategies and the leading players
The global economic downturn and equity market decline since the late 1990s badly affected the entire financial services industry and resulted in dramatic cuts in IT spending. Learn More